HOME >> MEDICINE >> NEWS
Using mobile phones reduces error rate in hospital care

Using mobile telephones in hospitals reduces the error rate in medical care because of more timely communication and rarely causes electronic magnetic interference, Yale School of Medicine researchers report this month.

The study published in February's Anesthesia & Analgesia is believed to be the first to investigate whether use of cell phones by medical personnel has a beneficial impact on safety. It was based on 4,018 responses from attendees at the 2003 meeting of the American Society of Anesthesiologists.

Of those anesthesiologists who participated in the survey, 65 percent reported using pagers as their primary mode of communications and 17 percent said they used cellular telephones. Forty percent of respondents who use pagers reported delays in communications, compared to 31 percent of cellular telephone users.

The senior author, Keith Ruskin, M.D., associate professor in the Departments of Anesthesiology and Neurosurgery, said the electronic interference from mobile telephone was a problem in the past because of older telemetry equipment and analog cell phones.

"The new digital cell phones used much higher power and operate at a different frequency," Ruskin said. "The small risks of electromagnetic interference between mobile telephones and medical devices should be weighed against the potential benefits of improved communication."

He said the reported 2.4 percent prevalence of electronic interference with life support devices such as ventilators, intravenous infusion pumps, and monitoring equipment is much lower than the 14.9 percent risk of observed medical error or injury due to a delay in communication.


'"/>

Contact: Jacqueline Weaver
jacqueline.weaver@yale.edu
203-432-8555
Yale University
27-Jan-2006


Page: 1

Related medicine news :

1. Using coxibs and NSAIDs to treat osteoarthritis
2. Using MRI for diagnosis could help prevent breast cancer progression
3. Using morphine to hasten death is a myth, says doctor
4. Using nanomagnets to enhance medical imaging
5. Using contrast enhanced sonography improves diagnosis of liver and spleen injuries
6. Using device to give CPR does not improve survival
7. Using HPV testing to screen for cervical cancer
8. Citizen consumers? Using public services is not like shopping
9. Using statins to potentially treat rheumatoid arthritis
10. Urgent need for guidance on mobile phone use in clinical care
11. Passengers, not just mobile phones, contribute to road accidents

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Using mobile phones reduces error rate hospital care

(Date:5/21/2013)... (PRWEB) May 21, 2013 MedMar Healing ... drive to benefit Second Harvest Food Bank. Twenty-eight businesses, including ... participate in the food drive. The goal is to raise ... the economic problems facing their families in recent years. ... community and help those in need,” explains Douglas Chloupek of ...
(Date:5/21/2013)... recently published in the New England Journal of ... the University of Colorado School of Medicine finds that ... be used to identify individuals at risk for this ... common variant of the gene for mucin-5B, a protein ... the bronchial tubes. While this variant of the MUC5B ...
(Date:5/21/2013)... Research into genetic features of pulmonary fibrosis by ... of Medicine may lead to improved treatment of this ... by JAMA . , The study found that ... cases of pulmonary fibrosis, a chronic progressive disease with ... of the study, researchers may want to consider including ...
(Date:5/21/2013)... and technological research So Paulo Research Foundation, FAPESP, based ... estimated in US$ 680 million to support 17 Research, ... up to eleven years, subject to continuation reviews on ... the 17 RIDCs will come from FAPESP and the ... infrastructure). Host institutions will participate in a portion of ...
(Date:5/21/2013)... York (PRWEB) May 21, 2013 The ... robot lawsuit is nearing its conclusion in Washington ... Bloomberg.com, during closing statements yesterday, an attorney for the ... the company wanted to tie sales and services for ... the training to keep control of surgeons, to keep ...
Breaking Medicine News(10 mins):Health News:San Jose Cannabis Club Helps Feed Hungry Children with Second Harvest Food Bank 2Health News:Researchers find genetic risk factor for pulmonary fibrosis 2Health News:Researchers find genetic tie to improved survival time for pulmonary fibrosis 2Health News:Research at the cutting edge of knowledge 2Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 2Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 3Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 4
(Date:5/21/2013)... , May 21, 2013   Accuray Incorporated ... the publication of study results involving hundreds of ... Radiosurgery System, the most widely used form of ... followed 304 patients for a median of 5 ... found that 97 percent of patients with low-risk ...
(Date:5/21/2013)...  Janssen R&D Ireland (Janssen) today announced primary ... 3 PROMISE study demonstrating that use of the ... virologic response 12 weeks after the end of ... 1 chronic hepatitis C adult patients with compensated ... when administered once daily with pegylated interferon and ...
(Date:5/21/2013)... , May 21, 2013 Abaxis, Inc. (NasdaqGS: ... systems, announced today that Martin Mulroy ... Stifel Annual Dental & Veterinary Conference on Wednesday, May ... be held at Le Parker Meridien Hotel in ... Abaxis Abaxis develops, manufactures, markets and sells ...
Breaking Medicine Technology:New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 2New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 2Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 4Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 5Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 6Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 7Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference 2
Cached News: